Peter Whorwell

Emeritus Professor Peter Whorwell is affiliated with the University of Manchester's Division of Diabetes, Endocrinology & Gastroenterology. He holds an ORCID ID (0000-0002-5220-8474) and specializes in functional gastrointestinal disorders, particularly irritable bowel syndrome (IBS), and innovative treatments like gut-directed hypnotherapy. His research spans epidemiology, pathophysiology, and clinical trial methodologies.

Education: BSc in Biochemistry from the University of London and MB BS (medicine) from Guy’s Hospital, London. Advanced training included US fellowships before his 1981 appointment at University Hospital of South Manchester, later becoming a Professor of Medicine and Gastroenterology at the University of Manchester.

Research focuses on mechanisms of hypnosis in gastrointestinal disorders, clinical trial design, and questionnaire-based symptom assessment. He has authored over 350 publications and advises international bodies like the Rome Foundation and NICE.

Key contributions include developing the Irritable Bowel Symptom Severity Scoring System and advocating for hypnotherapy as a treatment modality. He participates in global initiatives like the Rome Foundation’s epidemiology studies and chairs editorial boards (e.g., International Journal of Clinical and Experimental Hypnosis).

Impacts include improving patient care through evidence-based guidelines and public education via media engagements (e.g., Manchester Evening News, Daily Mail).